| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
146,000,000 |
| Market
Cap: |
16.60(B) |
| Last
Volume: |
2,843,953 |
Avg
Vol: |
1,347,527 |
| 52
Week Range: |
$92.79 - $209.935 |
|
| Level
I Sector: |
Information Technology |
| Level
II Sector: |
Electronics |
| Level
III Sector: |
Scientific & Technical Instruments |
|
Member Indexes:
|
| |
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
| |
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : 11.4 |
| Insider 3/6 Months : 12 |
|
| Guru Rank Number : 691 |
| Guru Rank Value : 2.3 |
| Guru Occurances : 3 |
|
|
|
|
|
| |
|
Company Profile Illumina is engaged in sequencing- and array-based solutions for genetic and genomic analysis. Co. provides whole-genome sequencing, genotyping, noninvasive prenatal testing (NIPT), and product support services. Using Co.'s services, customers can perform whole-genome sequencing projects and microarray projects (including large-scale genotyping studies and whole-genome association studies). Co. provides NIPT services through its partner laboratories that direct samples to Co. on a test send-out basis in its Clinical Laboratory Improvements Amendments-certified, College of Pathologists-accredited laboratory. Co. also provides support services to customers who have purchased its products.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
7,330 |
7,330 |
7,330 |
| Total Buy Value |
$0 |
$991,672 |
$991,672 |
$991,672 |
| Total People Bought |
0 |
1 |
1 |
1 |
| Total Buy Transactions |
0 |
1 |
1 |
1 |
| Total Shares Sold |
0 |
0 |
1,815 |
22,740 |
| Total Sell Value |
$0 |
$0 |
$314,105 |
$4,648,975 |
| Total People Sold |
0 |
0 |
2 |
3 |
| Total Sell Transactions |
0 |
0 |
4 |
17 |
| End Date |
2024-03-10 |
2023-12-08 |
2023-06-09 |
2022-06-09 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Aravanis Alexander |
SVP, Chief Technology Officer |
• • – |
2023-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
10,074 |
12,996 |
|
- |
|
| Febbo Phillip G. |
SVP Chief Medical Officer |
• • – |
2023-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
7,556 |
14,786 |
|
- |
|
| Tousi Susan H |
SVP, Chief Commercial Officer |
• • – |
2023-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
10,074 |
52,022 |
|
- |
|
| Goswami Joydeep |
SVP Chief Financial Officer |
• • – |
2023-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
10,074 |
20,726 |
|
- |
|
| Aravanis Alexander |
SVP, Chief Technology Officer |
• • – |
2023-02-22 |
4 |
AS |
$201.42 |
$1,088,982 |
D/D |
(5,398) |
2,922 |
|
-7% |
|
| Pegels Kevin Carl |
Chief of Global Operations |
• • – |
2023-02-21 |
4 |
D |
$202.84 |
$82,962 |
D/D |
(409) |
7,130 |
|
- |
|
| Pegels Kevin Carl |
Chief of Global Operations |
• • – |
2023-02-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,097 |
7,539 |
|
- |
|
| Reeves Kathryne Gambrell |
SVP, Chief Marketing Officer |
• • – |
2023-02-21 |
4 |
D |
$202.84 |
$142,799 |
D/D |
(704) |
6,269 |
|
- |
|
| Reeves Kathryne Gambrell |
SVP, Chief Marketing Officer |
• • – |
2023-02-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,789 |
6,973 |
|
- |
|
| Hoyt Aimee L |
SVP, Chief People Officer |
• • – |
2023-02-21 |
4 |
D |
$202.84 |
$276,877 |
D/D |
(1,365) |
6,798 |
|
- |
|
| Hoyt Aimee L |
SVP, Chief People Officer |
• • – |
2023-02-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,282 |
8,163 |
|
- |
|
| Febbo Phillip G. |
SVP Chief Medical Officer |
• • – |
2023-02-21 |
4 |
D |
$202.84 |
$252,536 |
D/D |
(1,245) |
7,230 |
|
- |
|
| Febbo Phillip G. |
SVP Chief Medical Officer |
• • – |
2023-02-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,522 |
8,475 |
|
- |
|
| Goswami Joydeep |
SVP Chief Financial Officer |
• • – |
2023-02-21 |
4 |
D |
$202.84 |
$332,658 |
D/D |
(1,640) |
10,652 |
|
- |
|
| Goswami Joydeep |
SVP Chief Financial Officer |
• • – |
2023-02-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,696 |
12,292 |
|
- |
|
| Dadswell Charles |
SVP & General Counsel |
• • – |
2023-02-21 |
4 |
D |
$202.84 |
$386,816 |
I/I |
(1,907) |
10,041 |
|
- |
|
| Dadswell Charles |
SVP & General Counsel |
• • – |
2023-02-21 |
4 |
OE |
$0.00 |
$0 |
I/I |
5,282 |
11,948 |
|
- |
|
| Tousi Susan H |
SVP, Chief Commercial Officer |
• • – |
2023-02-21 |
4 |
D |
$202.84 |
$445,639 |
D/D |
(2,197) |
41,948 |
|
- |
|
| Tousi Susan H |
SVP, Chief Commercial Officer |
• • – |
2023-02-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,869 |
44,145 |
|
- |
|
| Aravanis Alexander |
SVP, Chief Technology Officer |
• • – |
2023-02-21 |
4 |
D |
$202.84 |
$789,859 |
D/D |
(3,894) |
8,320 |
|
- |
|
| Aravanis Alexander |
SVP, Chief Technology Officer |
• • – |
2023-02-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,292 |
12,214 |
|
- |
|
| Desouza Francis A |
President and CEO |
• • – |
2023-02-21 |
4 |
D |
$202.84 |
$2,212,376 |
D/D |
(10,907) |
89,512 |
|
- |
|
| Desouza Francis A |
President and CEO |
• • – |
2023-02-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
23,473 |
100,419 |
|
- |
|
| Tousi Susan H |
SVP, Chief Commercial Officer |
• • – |
2023-02-06 |
4 |
AS |
$211.57 |
$105,785 |
D/D |
(500) |
38,276 |
|
1% |
|
| Hoyt Aimee L |
SVP, Chief People Officer |
• • – |
2023-01-09 |
4 |
AS |
$205.57 |
$179,051 |
D/D |
(871) |
2,796 |
|
-3% |
|
3467 Records found
|
|
Page 4 of 139 |
|
|
1.02 (0.88%) 
